These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35226675)
1. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury. Kim AS; Werlin EC; Kagaya H; Chen M; Wu B; Mottola G; Jan M; Conte MS PLoS One; 2022; 17(2):e0264217. PubMed ID: 35226675 [TBL] [Abstract][Full Text] [Related]
2. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury. Wu B; Mottola G; Chatterjee A; Lance KD; Chen M; Siguenza IO; Desai TA; Conte MS J Vasc Surg; 2017 Jan; 65(1):207-217.e3. PubMed ID: 27034112 [TBL] [Abstract][Full Text] [Related]
3. Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model. Makino Y; Miyahara T; Nitta J; Miyahara K; Seo A; Kimura M; Suhara M; Akai A; Akagi D; Yamamoto K; Hoshina K J Surg Res; 2019 Jan; 233():104-110. PubMed ID: 30502235 [TBL] [Abstract][Full Text] [Related]
4. Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model. Mottola G; Werlin EC; Wu B; Chen M; Chatterjee A; Schaller MS; Conte MS Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106401. PubMed ID: 31841663 [TBL] [Abstract][Full Text] [Related]
5. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries. Levy ES; Kim AS; Werlin E; Chen M; Sansbury BE; Spite M; Desai TA; Conte MS JVS Vasc Sci; 2023; 4():100126. PubMed ID: 38045567 [TBL] [Abstract][Full Text] [Related]
6. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model. Wu B; Werlin EC; Chen M; Mottola G; Chatterjee A; Lance KD; Bernards DA; Sansbury BE; Spite M; Desai TA; Conte MS J Vasc Surg; 2018 Dec; 68(6S):188S-200S.e4. PubMed ID: 30064835 [TBL] [Abstract][Full Text] [Related]
7. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway. Mottola G; Chatterjee A; Wu B; Chen M; Conte MS PLoS One; 2017; 12(3):e0174936. PubMed ID: 28362840 [TBL] [Abstract][Full Text] [Related]
9. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice. Akagi D; Chen M; Toy R; Chatterjee A; Conte MS FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995 [TBL] [Abstract][Full Text] [Related]
10. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Bang S; Yoo S; Yang TJ; Cho H; Hwang SW Br J Pharmacol; 2012 Feb; 165(3):683-92. PubMed ID: 21718307 [TBL] [Abstract][Full Text] [Related]
11. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model. Guan S; Tang Q; Liu W; Zhu R; Li B Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery. Larifla L; Déprez I; Pham I; Rideau D; Louzier V; Adam M; Eloit M; Foucan L; Adnot S; Teiger E J Gene Med; 2012 Jul; 14(7):459-67. PubMed ID: 22645072 [TBL] [Abstract][Full Text] [Related]
13. Neuropilins 1 and 2 mediate neointimal hyperplasia and re-endothelialization following arterial injury. Pellet-Many C; Mehta V; Fields L; Mahmoud M; Lowe V; Evans I; Ruivo J; Zachary I Cardiovasc Res; 2015 Nov; 108(2):288-98. PubMed ID: 26410366 [TBL] [Abstract][Full Text] [Related]
14. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent. Orr SK; Colas RA; Dalli J; Chiang N; Serhan CN Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L904-11. PubMed ID: 25770181 [TBL] [Abstract][Full Text] [Related]
15. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration. Shi J; Zhang X; Jiang L; Zhang L; Dong Y; Midgley AC; Kong D; Wang S Acta Biomater; 2019 Oct; 97():360-373. PubMed ID: 31351251 [TBL] [Abstract][Full Text] [Related]
16. Galangin inhibits neointima formation induced by vascular injury Wu B; Xu C; Ding HS; Qiu L; Gao JX; Li M; Xiong Y; Xia H; Liu X Food Funct; 2022 Nov; 13(23):12077-12092. PubMed ID: 36367287 [No Abstract] [Full Text] [Related]
17. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. Sun YP; Oh SF; Uddin J; Yang R; Gotlinger K; Campbell E; Colgan SP; Petasis NA; Serhan CN J Biol Chem; 2007 Mar; 282(13):9323-9334. PubMed ID: 17244615 [TBL] [Abstract][Full Text] [Related]
18. Compound K, an intestinal metabolite of ginsenosides, inhibits PDGF-BB-induced VSMC proliferation and migration through G1 arrest and attenuates neointimal hyperplasia after arterial injury. Park ES; Lee KP; Jung SH; Lee DY; Won KJ; Yun YP; Kim B Atherosclerosis; 2013 May; 228(1):53-60. PubMed ID: 23473423 [TBL] [Abstract][Full Text] [Related]
19. Cell-Specific Effects of GATA (GATA Zinc Finger Transcription Factor Family)-6 in Vascular Smooth Muscle and Endothelial Cells on Vascular Injury Neointimal Formation. Zhuang T; Liu J; Chen X; Pi J; Kuang Y; Wang Y; Tomlinson B; Chan P; Zhang Q; Li Y; Yu Z; Zheng X; Reilly M; Morrisey E; Zhang L; Liu Z; Zhang Y Arterioscler Thromb Vasc Biol; 2019 May; 39(5):888-901. PubMed ID: 30943773 [TBL] [Abstract][Full Text] [Related]
20. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury. Tang H; Liu Y; Yan C; Petasis NA; Serhan CN; Gao H J Immunol; 2014 Oct; 193(7):3769-78. PubMed ID: 25172497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]